{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:25:19Z","timestamp":1761899119869,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.cancergen.2017.07.007","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T16:51:40Z","timestamp":1501779100000},"page":"91-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia\/lymphoma without eosinophilia"],"prefix":"10.1016","volume":"216-217","author":[{"given":"Matthew J.","family":"Oberley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Denton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianling","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hiemenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Bhojwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejerianne","family":"Ostrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Gaynon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordana","family":"Raca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2017.07.007_bib0010","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0015","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0020","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3324\/haematol.2009.021675","article-title":"Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1","volume":"95","author":"Bain","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1309\/AJCPMORR5Z2IKCEM","article-title":"Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1","volume":"144","author":"Vega","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0030","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.leu.2404662","article-title":"Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma","volume":"21","author":"Metzgeroth","year":"2007","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.cancergen.2017.07.007_bib0035","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MD.0b013e3182a71eba","article-title":"The spectrum of FIP1L1-PDGFRA-associated chronic eosinophilic leukemia: new insights based on a survey of 44 cases","volume":"92","author":"Legrand","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.mph.0000193467.06938.77","article-title":"Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement","volume":"27","author":"Rives","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0045","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/pbc.22655","article-title":"Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate","volume":"55","author":"Rathe","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0050","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/MPH.0b013e31827e6386","article-title":"FIP1L1-PDGFR\u03b1-positive hypereosinophilic syndrome in childhood: a case report and review of literature","volume":"36","author":"Farruggia","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"issue":"14 suppl","key":"10.1016\/j.cancergen.2017.07.007_bib0055","article-title":"A comprehensive gene panel for precise diagnosis and treatment of childhood cancer","volume":"76","author":"Triche","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0060","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/sj.leu.2404302","article-title":"Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast","volume":"20","author":"Graux","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0065","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.3324\/haematol.2014.112151","article-title":"Clinical features and outcome of SIL\/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group","volume":"100","author":"D'Angi\u00f2","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0070","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood-2003-05-1495","article-title":"Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951","volume":"103","author":"Cav\u00e9","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2008-07-166801","article-title":"A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups","volume":"113","author":"Sulong","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0080","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/leu.2008.287","article-title":"Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias","volume":"22","author":"Gotlib","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/leu.2008.310","article-title":"The molecular anatomy of the FIP1L1-PDGFRA fusion gene","volume":"23","author":"Walz","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0090","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1200\/JCO.2004.05.140","article-title":"Biology of gastrointestinal stromal tumors","volume":"22","author":"Corless","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0095","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0100","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2141.1992.tb08896.x","article-title":"Interstitial 9q deletion in T-lymphoid\/myeloid biphenotypic leukaemia","volume":"80","author":"Akashi","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0110","first-page":"1990","article-title":"Interstitial 9q deletion is associated with CD7+ acute leukemia of myeloid and T lymphoid lineage","volume":"10","author":"Ferrara","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0115","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/pbc.22850","article-title":"Successful treatment of a child with T\/myeloid acute bilineal leukemia associated with TLX3\/BCL11B fusion and 9q deletion","volume":"56","author":"Oliveira","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0120","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","article-title":"High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults","volume":"35","author":"Roberts","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0125","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1002\/ajh.24273","article-title":"Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation","volume":"91","author":"Pardanani","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/leu.2011.181","article-title":"Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation","volume":"26","author":"Metzgeroth","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2017.07.007_bib0135","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/leu.2009.2","article-title":"FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib","volume":"23","author":"Lierman","year":"2009","journal-title":"Leukemia"},{"issue":"suppl 3","key":"10.1016\/j.cancergen.2017.07.007_bib0140","first-page":"iii21","article-title":"Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","year":"2014","journal-title":"Ann Oncol"},{"issue":"suppl","key":"10.1016\/j.cancergen.2017.07.007_bib0145","article-title":"Dose escalating study of crenolanib besylate in advanced GIST patients with PDGFRA D842V activating mutations (abstract)","volume":"34","author":"von Mehren","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217302454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217302454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:42:39Z","timestamp":1761896559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776217302454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":28,"alternative-id":["S2210776217302454"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2017.07.007","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia\/lymphoma without eosinophilia","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2017.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}